Yu Sheng Wu

University of Toronto - Toronto / Canada

Others

AD Scientific Index ID: 667880

Registration, Add Profile,
Premium Membership

Print Your Certificate

Yu Sheng Wu's MOST POPULAR ARTICLES

1-) Some gating potentiators, including VX-770, diminish ΔF508-CFTR functional expressionG Veit, RG Avramescu, D Perdomo, PW Phuan, M Bagdany, PM Apaja, ...Science translational medicine 6 (246), 246ra97-246ra97, 20142862014

2-) SLC6A14 Is a Genetic Modifier of Cystic Fibrosis That Regulates Pseudomonas aeruginosa Attachment to Human Bronchial Epithelial CellsM Di Paola, AJ Park, S Ahmadi, EJ Roach, YS Wu, M Struder-Kypke, ...MBio 8 (6), 10.1128/mbio. 02073-17, 2017512017

3-) ORKAMBI-mediated rescue of mucociliary clearance in cystic fibrosis primary respiratory cultures is enhanced by arginine uptake, arginase inhibition, and promotion of nitric …YS Wu, J Jiang, S Ahmadi, A Lew, O Laselva, S Xia, C Bartlett, W Ip, ...Molecular pharmacology 96 (4), 515-525, 2019502019

4-) Lipophilicity of the cystic fibrosis drug, ivacaftor (VX-770), and its destabilizing effect on the major CF-causing mutation: F508delS Chin, M Hung, A Won, YS Wu, S Ahmadi, D Yang, S Elmallah, K Toutah, ...Molecular pharmacology 94 (2), 917-925, 2018442018

5-) SLC6A14, an amino acid transporter, modifies the primary CF defect in fluid secretionS Ahmadi, S Xia, YS Wu, M Di Paola, R Kissoon, C Luk, F Lin, K Du, ...Elife 7, e37963, 2018402018

ARTICLES

Add your articles